AAAAAA
Results: 476-500/15678
Authors:
Poonawala, A
Nair, SP
Thuluvath, PJ
Citation: A. Poonawala et al., Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis:A case-control study, HEPATOLOGY, 32(4), 2000, pp. 689-692
Authors:
Reich, DJ
Fiel, I
Guarrera, JV
Emre, S
Guy, SR
Schwartz, ME
Miller, CM
Sheiner, PA
Citation: Dj. Reich et al., Liver transplantation for autoimmune hepatitis, HEPATOLOGY, 32(4), 2000, pp. 693-700
Authors:
Van Gijssel, HE
Ohlson, LCE
Torndal, UB
Mulder, GJ
Eriksson, LC
Porsch-Hallstrom, I
Meerman, JHN
Citation: He. Van Gijssel et al., Loss of nuclear p53 protein in preneoplastic rat hepatocytes is accompanied by Mdm2 and Bcl-2 overexpression and by defective response to DNA damage in vivo, HEPATOLOGY, 32(4), 2000, pp. 701-710
Authors:
Masaki, T
Shiratori, Y
Rengifo, W
Igarashi, K
Matsumoto, K
Nishioka, M
Hatanaka, Y
Omata, M
Citation: T. Masaki et al., Hepatocellular carcinoma cell cycle: Study of Long-Evans Cinnamon rats, HEPATOLOGY, 32(4), 2000, pp. 711-720
Authors:
Liao, C
Zhao, M
Song, H
Uchida, K
Yokoyama, KK
Li, TP
Citation: C. Liao et al., Identification of the gene for a novel liver-related putative tumor suppressor at a high-frequency loss of heterozygosity region of chromosome 8p23 in human hepatocellular carcinoma, HEPATOLOGY, 32(4), 2000, pp. 721-727
Authors:
Nicoletti, F
Di Marco, R
Zaccone, P
Salvaggio, A
Magro, G
Bendtzen, K
Meroni, P
Citation: F. Nicoletti et al., Murine concanavalin A-induced hepatitis is prevented by interleukin 12 (IL-12) antibody and exacerbated by exogenous IL-12 through an interferon-gamma-dependent mechanism, HEPATOLOGY, 32(4), 2000, pp. 728-733
Authors:
Rolando, N
Wade, J
Davalos, M
Wendon, J
Philpott-Howard, J
Williams, R
Citation: N. Rolando et al., The systemic inflammatory response syndrome in acute liver failure, HEPATOLOGY, 32(4), 2000, pp. 734-739
Authors:
Will, Y
Fischer, KA
Horton, RA
Kaetzel, RS
Brown, MK
Hedstrom, O
Lieberman, MW
Reed, DJ
Citation: Y. Will et al., gamma-Glutamyltranspeptidase-deficient knockout mice as a model to study the relationship between glutathione status, mitochondrial function, and cellular function, HEPATOLOGY, 32(4), 2000, pp. 740-749
Authors:
Freathy, C
Brown, DG
Roberts, RA
Cain, K
Citation: C. Freathy et al., Transforming growth factor-beta(1) induces apoptosis in rat FaO hepatoma cells via cytochrome c release and oligomerization of Apaf-1 to form a similar to 700-kd apoptosome caspase-processing complex, HEPATOLOGY, 32(4), 2000, pp. 750-760
Authors:
Shimonishi, T
Isse, K
Shibata, F
Aburatani, I
Tsuneyama, K
Sabit, H
Harada, K
Miyazaki, K
Nakanuma, Y
Citation: T. Shimonishi et al., Up-regulation of Fas ligand at early stages and down-regulation of Fas at progressed stages of intrahepatic cholangiocarcinoma reflect evasion from immune surveillance, HEPATOLOGY, 32(4), 2000, pp. 761-769
Authors:
Kim, YM
Kim, TH
Chung, HT
Talanian, RV
Yin, XM
Billiar, TR
Citation: Ym. Kim et al., Nitric oxide prevents tumor necrosis factor alpha-induced rat hepatocyte apoptosis by the interruption of mitochondrial apoptotic signaling through S-nitrosylation of caspase-8, HEPATOLOGY, 32(4), 2000, pp. 770-778
Authors:
Schlosser, SF
Azzaroli, F
Dao, T
Hingorani, R
Crispe, IN
Boyer, JL
Citation: Sf. Schlosser et al., Induction of murine hepatocyte death by membrane-bound CD95 (Fas/APO-1)-ligand: Characterization of an in vitro system, HEPATOLOGY, 32(4), 2000, pp. 779-785
Authors:
Pastor, CM
Hadengue, A
Citation: Cm. Pastor et A. Hadengue, Shear stress modulates the vascular tone in perfused livers isolated from normal rats, HEPATOLOGY, 32(4), 2000, pp. 786-791
Authors:
Borlak, J
Thum, T
Landt, O
Erb, K
Hermann, R
Citation: J. Borlak et al., Molecular diagnosis of a familial nonhemolytic hyperbilirubinemia (Gilbert's syndrome) in healthy subjects, HEPATOLOGY, 32(4), 2000, pp. 792-795
Authors:
Suzuki, A
Hayashida, M
Kawano, H
Sugimoto, K
Nakano, T
Shiraki, K
Citation: A. Suzuki et al., Hepatocyte growth factor promotes cell survival from Fas-mediated cell death in hepatocellular carcinoma cells via Akt activation and Fas-death-inducing signaling complex suppression, HEPATOLOGY, 32(4), 2000, pp. 796-802
Authors:
Song, BC
Suh, DJ
Lee, HC
Chung, YH
Lee, YS
Citation: Bc. Song et al., Hepatitis B e antigen seroconversion after lamivudine therapy is not durable in patients with chronic hepatitis B in Korea, HEPATOLOGY, 32(4), 2000, pp. 803-806
Authors:
Cote, PJ
Toshkov, I
Bellezza, C
Ascenzi, M
Roneker, C
Graham, LA
Baldwin, BH
Gaye, K
Nakamura, I
Korba, BE
Tennant, BC
Gerin, JL
Citation: Pj. Cote et al., Temporal pathogenesis of experimental neonatal woodchuck hepatitis virus infection: Increased initial viral load and decreased severity of acute hepatitis during the development of chronic viral infection, HEPATOLOGY, 32(4), 2000, pp. 807-817
Authors:
Sarrazin, C
Teuber, G
Kokka, R
Rabenau, H
Zeuzem, S
Citation: C. Sarrazin et al., Detection of residual hepatitis C virus RNA by transcription-mediated amplification in patients with complete virologic response according to polymerase chain reaction-based assays, HEPATOLOGY, 32(4), 2000, pp. 818-823
Authors:
Gaeta, GB
Stroffolini, T
Chiaramonte, M
Ascione, T
Stornaiuolo, G
Lobello, S
Sagnelli, E
Brunetto, MR
Rizzetto, M
Citation: Gb. Gaeta et al., Chronic hepatitis D: A vanishing disease? An Italian multicenter study, HEPATOLOGY, 32(4), 2000, pp. 824-827
Authors:
Lu, DTY
Khokhar, MF
Doo, E
Ghany, MG
Herion, D
Park, Y
Kleiner, DE
Schmid, P
Condreay, LD
Gauthier, J
Kuhns, MC
Liang, TJ
Hoofnagle, JH
Citation: Dty. Lu et al., Long-term therapy of chronic hepatitis B with lamivudine, HEPATOLOGY, 32(4), 2000, pp. 828-834
Authors:
Zeuzem, S
Teuber, G
Naumann, U
Berg, T
Raedle, J
Hartmann, S
Hopf, U
Citation: S. Zeuzem et al., Randomized, double-blind, placebo-controlled trial of interferon Alfa2a with and without amantadine as initial treatment for chronic hepatitis C, HEPATOLOGY, 32(4), 2000, pp. 835-841
Authors:
McMahon, BJ
Bulkow, L
Harpster, A
Snowball, M
Lanier, A
Sacco, F
Dunaway, E
Williams, J
Citation: Bj. Mcmahon et al., Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: A 16-year population-based study, HEPATOLOGY, 32(4), 2000, pp. 842-846
Authors:
Hadziyannis, SJ
Papatheodoridis, GV
Dimou, E
Laras, A
Papaioannou, C
Citation: Sj. Hadziyannis et al., Efficacy of long-term lamivudine monotherapy in patients with hepatitis B e antigen-negative chronic hepatitis B, HEPATOLOGY, 32(4), 2000, pp. 847-851
Authors:
Berenguer, M
Prieto, M
Rayon, JM
Mora, J
Pastor, M
Ortiz, V
Carrasco, D
San Juan, F
Burgueno, MDJ
Mir, J
Berenguer, J
Citation: M. Berenguer et al., Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation, HEPATOLOGY, 32(4), 2000, pp. 852-858
Authors:
Fallon, MB
Abrams, GA
Citation: Mb. Fallon et Ga. Abrams, Pulmonary dysfunction in chronic liver disease, HEPATOLOGY, 32(4), 2000, pp. 859-865